|
|
Blood, 1 June 2005, Vol. 105, No. 11, pp. 4437-4444.
Prepublished online as a Blood First Edition Paper on January 21, 2005; DOI 10.1182/blood-2004-08-2976.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
TEF, an antiapoptotic bZIP transcription factor related to the oncogenic E2A-HLF chimera, inhibits cell growth by down-regulating expression of the common  chain of cytokine receptors
Takeshi Inukai,
Toshiya Inaba,
Jinjun Dang,
Ryoko Kuribara,
Keiya Ozawa,
Atsushi Miyajima,
Wenshu Wu,
A. Thomas Look,
Yojiro Arinobu,
Hiromi Iwasaki,
Koichi Akashi,
Keiko Kagami,
Kumiko Goi,
Kanji Sugita, and
Shinpei Nakazawa
From the Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan; Department of Molecular Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan; Department of Experimental Oncology, St Jude Children's Research Hospital, Memphis, TN; Division of Hematology, Jichi Medical School, Tochigi, Japan; Institute of Molecular and Cellular Bioscience, the University of Tokyo, Tokyo, Japan; Pediatric Oncology Department and Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, MA.
Gain and/or loss of function mediated by chimeric transcription factors generated by nonrandom translocations in leukemia is a key to understanding oncogenesis. E2A–hepatic leukemia factor (HLF), a chimeric basic region/leucine zipper (bZIP) transcription factor expressed in t(17;19)–positive leukemia cells, contributes to leukemogenesis through its potential to inhibit apoptosis. To identify physiologic counterparts of this chimera, we investigated the function of other bZIP factors that bind to the same DNA sequence recognized by E2A-HLF. Here, we show that thyrotroph embryonic factor (TEF), which shares a high level of sequence identity with HLF and recognizes the same DNA sequence, is expressed in a small fraction of each subset of hematolymphoid progenitors. When TEF was introduced into FL5.12 interleukin 3 (IL-3)–dependent cells, TEF protected the cells from apoptosis due to IL-3 deprivation. Unexpectedly, TEF also almost completely down-regulated expression of the common  (c) chain of cytokine receptors. Consequently, TEF-expressing cells accumulated in G0/G1 phase without undergoing apoptosis. These findings suggest that TEF is one of the apoptotic regulators in hematopoietic progenitors and controls hematopoietic-cell proliferation by regulating the expression of the c chain. In contrast, E2A-HLF promoted cell survival more efficiently than TEF but did not down-regulate c chain expression, suggesting that E2A-HLF retains ideal properties for driving leukemic transformation.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Benito, O. Gutierrez, C. Pipaon, P. J. Real, F. Gachon, A. E. Ritchie, and J. L. Fernandez-Luna
A Novel Role for Proline- and Acid-rich Basic Region Leucine Zipper (PAR bZIP) Proteins in the Transcriptional Regulation of a BH3-only Proapoptotic Gene
J. Biol. Chem.,
December 15, 2006;
281(50):
38351 - 38357.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
